BioDelivery Sciences (BDSI) Gains Preferred Formulary Status for BUNAVAIL
Tweet Send to a Friend
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced it has signed an agreement with a significant managed care provider providing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE